Franklin Resources’s Aegerion Pharmaceuticals AEGR Stock Holding History

Franklin Resources’s Portfolio AEGR Stock Details AEGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-26,576	Closed	-$79K	–	1547
2016 Q3	$79K	Buy	26,576 +11,664	+78%	+$20.2K	﹤0.01%	1483
2016 Q2	$22K	Buy	14,912 +3,881	+35%	+$8.88K	﹤0.01%	1496
2016 Q1	$41K	Buy	11,031 +976	+10%	+$6.04K	﹤0.01%	1504
2015 Q4	$102K	Sell	10,055 -116	-1%	-$1.4K	﹤0.01%	1561
2015 Q3	$138K	Buy	+10,171	New	+$181K	﹤0.01%	1565

Franklin Resources's AEGR Position: Q4 2016 in Review

Franklin Resources sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 26,576 shares — an estimated $79K sold.

Franklin Resources first reported a position in AEGR in Q3 2015 and held it in 5 quarters. The position peaked at $138K in Q3 2015. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

Franklin Resources reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Franklin Resources sold 26,576 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $79K.
Franklin Resources first reported a position in Aegerion Pharmaceuticals in Q3 2015 and held it in 5 quarters.
Franklin Resources's Aegerion Pharmaceuticals position peaked at $138K in Q3 2015.
0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on Franklin Resources's 13F filing for Q4 2016, filed 14 Feb 2017.